Literature DB >> 9600479

Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines.

E A Halm1, M J Fine, T J Marrie, C M Coley, W N Kapoor, D S Obrosky, D E Singer.   

Abstract

CONTEXT: Many groups have developed guidelines to shorten hospital length of stay in pneumonia in order to decrease costs, but the length of time until a patient hospitalized with pneumonia becomes clinically stable has not been established.
OBJECTIVE: To describe the time to resolution of abnormalities in vital signs, ability to eat, and mental status in patients with community-acquired pneumonia and assess clinical outcomes after achieving stability.
DESIGN: Prospective, multicenter, observational cohort study.
SETTING: Three university and 1 community teaching hospital in Boston, Mass, Pittsburgh, Pa, and Halifax, Nova Scotia. PATIENTS: Six hundred eighty-six adults hospitalized with community-acquired pneumonia. MAIN OUTCOME MEASURES: Time to resolution of vital signs, ability to eat, mental status, hospital length of stay, and admission to an intensive care, coronary care, or telemetry unit.
RESULTS: The median time to stability was 2 days for heart rate (< or =100 beats/min) and systolic blood pressure (> or =90 mm Hg), and 3 days for respiratory rate (< or =24 breaths/min), oxygen saturation (> or =90%), and temperature (< or =37.2 degrees C [99 degrees F]). The median time to overall clinical stability was 3 days for the most lenient definition of stability and 7 days for the most conservative definition. Patients with more severe cases of pneumonia at presentation took longer to reach stability. Once stability was achieved, clinical deterioration requiring intensive care, coronary care, or telemetry monitoring occurred in 1% of cases or fewer. Between 65% to 86% of patients stayed in the hospital more than 1 day after reaching stability, and fewer than 29% to 46% were converted to oral antibiotics within 1 day of stability, depending on the definition of stability.
CONCLUSIONS: Our estimates of time to stability in pneumonia and explicit criteria for defining stability can provide an evidence-based estimate of optimal length of stay, and outline a clinically sensible approach to improving the efficiency of inpatient management.

Entities:  

Mesh:

Year:  1998        PMID: 9600479     DOI: 10.1001/jama.279.18.1452

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  107 in total

1.  Community-Acquired Pneumonia: An Overview.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-04       Impact factor: 3.725

2.  A comparison between time to clinical stability in community-acquired aspiration pneumonia and community-acquired pneumonia.

Authors:  Philippe Jaoude; Jessica Badlam; Anil Anandam; Ali A El-Solh
Journal:  Intern Emerg Med       Date:  2012-03-06       Impact factor: 3.397

3.  Biomarkers for Predicting Illness Severity in Children With Acute Lower Respiratory Tract Infections.

Authors:  Samir S Shah; Lilliam Ambroggio; Todd A Florin
Journal:  J Pediatric Infect Dis Soc       Date:  2014-05-14       Impact factor: 3.164

4.  Severe community acquired pneumonia.

Authors:  Graham D Mills; Richard Laing
Journal:  BMJ       Date:  2006-12-09

5.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

6.  Factors associated with length of stay in hospital for suspected community-acquired pneumonia.

Authors:  Jane Q Huang; Peter M Hooper; Thomas J Marrie
Journal:  Can Respir J       Date:  2006-09       Impact factor: 2.409

7.  Community-acquired pneumonia: 2012 history, mythology, and science.

Authors:  Gerald R Donowitz
Journal:  Trans Am Clin Climatol Assoc       Date:  2013

8.  A tailored implementation strategy to reduce the duration of intravenous antibiotic treatment in community-acquired pneumonia: a controlled before-and-after study.

Authors:  M F Engel; A H W Bruns; M E J L Hulscher; C A J M Gaillard; S U C Sankatsing; F Teding van Berkhout; M H Emmelot-Vonk; E M Kuck; M H M Steeghs; J H den Breeijen; R K Stellato; A I M Hoepelman; J J Oosterheert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-26       Impact factor: 3.267

9.  Time to clinical stability among children hospitalized with pneumonia.

Authors:  Rachel B Wolf; Kathryn Edwards; Carlos G Grijalva; Wesley H Self; Yuwei Zhu; James Chappell; Anna M Bramley; Seema Jain; Derek J Williams
Journal:  J Hosp Med       Date:  2015-04-28       Impact factor: 2.960

10.  Limited impact of a multicenter intervention to improve the quality and efficiency of pneumonia care.

Authors:  Ethan A Halm; Carol Horowitz; Alan Silver; Alan Fein; Yosef D Dlugacz; Bruce Hirsch; Mark R Chassin
Journal:  Chest       Date:  2004-07       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.